OncoMed Pharmaceuticals, Inc. Gross Margin 2013-2018 | OMED

Current and historical gross margin for OncoMed Pharmaceuticals, Inc. (OMED) over the last 10 years. The current gross profit margin for OncoMed Pharmaceuticals, Inc. as of December 31, 2018 is %.
Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2018-12-31 $0.05B $0.05B 100.00%
2018-09-30 $0.06B $0.06B 100.00%
2018-06-30 $0.04B $0.04B 100.00%
2018-03-31 $0.04B $0.04B 100.00%
2017-12-31 $0.04B $0.04B 100.00%
2017-09-30 $0.02B $0.02B 100.00%
2017-06-30 $0.02B $0.02B 100.00%
2017-03-31 $0.03B $0.03B 100.00%
2016-12-31 $0.03B $0.03B 100.00%
2016-09-30 $0.03B $0.03B 100.00%
2016-06-30 $0.03B $0.03B 100.00%
2016-03-31 $0.02B $0.02B 100.00%
2015-12-31 $0.03B $0.03B 100.00%
2015-09-30 $0.03B $0.03B 100.00%
2015-06-30 $0.04B $0.04B 100.00%
2015-03-31 $0.04B $0.04B 100.00%
2014-12-31 $0.04B $0.04B 100.00%
2014-09-30 $0.05B $0.05B 100.00%
2014-06-30 $0.04B $0.04B 100.00%
2014-03-31 $0.04B $0.04B 100.00%
2013-12-31 $0.04B $0.04B 100.00%
2013-09-30 $0.03B $0.03B 100.00%
2013-06-30 $0.02B $0.02B 100.00%